APA

Olsson A., Oturai D. B., Sørensen P. S., Oturai P. S. & Oturai A. B. (20160720). Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Olsson A, Oturai D B, Sørensen P S, Oturai P S and Oturai A B. 20160720. Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Olsson A., Oturai D. B., Sørensen P. S., Oturai P. S. and Oturai A. B. (20160720). Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Olsson A, Oturai D B, Sørensen P S, Oturai P S and Oturai A B. Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England). 20160720.